Zheng Quan Ri Bao Wang·2025-11-14 11:45Core Viewpoint - Fuxiang Pharmaceutical (300497) announced plans to increase its production capacity for VC and FEC products, indicating a strategic response to market demand and industry capacity release [1] Group 1: Production Capacity - The company currently has a production capacity of 8,000 tons per year for VC products and approximately 4,000 tons per year for FEC products [1] - Plans are in place to enhance VC production capacity to 10,000 tons per year, with the upgrade expected to be completed by the second quarter of 2026 [1] - Future capacity expansions may increase VC production to 20,000 tons per year and FEC production to 5,000 tons per year, depending on market demand and industry conditions [1] Group 2: Key Customers - Major customers for the company's VC and FEC products include Tianqi Materials (002709) and Xinjubang (300037) [1]